General Partner and CFO
Susie Harborth is General Partner and CFO of BioInnovation Capital, an early stage life science venture capital firm. She co-founded and oversees BioLabs San Diego and the BioLabs network. From 2010 to 2014, Susie was Chief Financial Officer (CFO) and Senior Vice President of Operations at GnuBIO, Inc., a next-generation DNA sequencing company that was spun out of Harvard University. GnuBIO was acquired in 2014 by Bio-Rad Laboratories. Susie specializes in launching early-stage life science companies, supporting founders from idea to exit. Prior to GnuBIO, she helped launch two successful start-ups with Peter Parker: Cequent Pharmaceuticals and Boston Heart Diagnostics. She developed the initial infrastructure at both ventures and provided management in finance, human resources, information technology, and vendor/investor relations. Prior to Cequent Pharmaceuticals, Susie worked with institutional investors at Leerink Partners LLC, a life science investment bank. She received a master in biology from Harvard University and did her graduate research in breast cancer diagnostics at Massachusetts General Hospital (MGH) and bachelors in finance from California State University, Long Beach.